Find a Specialist by Postal Code | Page 5 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Elie Traer, MD, PhD OHSU Knight Cancer Institute Beaverton Oregon United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Matt Kalaycio, MD Cleveland Clinic Taussig Cancer Center Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Joshua Sasine, MD, PhD Cedars-Sinai Los Angeles California United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Jonathon B. Cohen, MD, MS Emory University Atlanta Georgia United States
  • Chronic Lymphocytic Leukemia (CLL)
Harry Erba, MD, PhD Duke Cancer Center Durham North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Tian Yi Zhang, MD, PhD Stanford University School of Medicine Stanford California United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
David B. Sykes, MD, PhD Mass General Hospital Boston Massachusetts United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Namrata Chandhok, MD University of Miami Health System - Sylvester Comprehensive Cancer Center Miami Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Anthony Hunter, MD Winship Cancer Institute of Emory University Atlanta Georgia United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Carlos E. Vigil, MD University of Iowa Clinic and Hospitals Iowa City Iowa United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Myelodysplastic Syndromes (MDS)
Pamela Stratton, MD FACOG National Institute of Child Health and Human Development Bethesda Maryland United States
  • Graft Versus Host Disease (GVHD)
Michael Savona, MD Vanderbilt University Medical Center Malignant Hematology Clinic Nashville Tennessee United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Larry D. Cripe, MD Indiana University Health Indianapolis Indiana United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
David Araten, MD NYU School of Medicine New York City New York United States
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Mehmet Copur, MD, FACP Marylanning Health Care Hastings Nebraska United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Yasmin Abaza, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Steven Gore, M.D. National Cancer Institute - NCI Bethesda Maryland United States
  • Myelodysplastic Syndromes (MDS)
Damian Laber, MD Moffit Cancer Center Tampa Florida United States
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Hemant Murthy, MD Mayo Clinic - Jacksonville Jacksonville Florida United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Robert Collins, MD Harold C. Simmons Comprehensive Cancer Center Dallas Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)